Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Parsaclisib hydrochloride | 1995889-48-9 | 99.3% | 469.34 | 1 MG
SDP

Catalog No. 5000343309
Encompass_Preferred

Parsaclisib hydrochloride is a potent, selective, and orally active inhibitor of PI3Kδ, with an IC50 of 1 nM at 1 mM ATP. It exhibits approximately 20000-fold selectivity over other PI3K class I isoforms and is used for the research of relapsed or refractory B-cell malignancies.

  • Potent, selective, and orally active inhibitor of PI3Kδ
  • High potency and selectivity for PI3Kδ
  • Used for research of relapsed or refractory B-cell malignancies
  • Inhibits proliferation of MCL and DLBCL cell lines
  • Inhibits tumor growth in BALB/c mice bearing A20 murine lymphoma cells
  • Potential therapeutic agent for B-cell malignancies

Catalog No. 50-003-43309 Supplier Medchemexpress LLC Supplier No. HY109068A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Parsaclisib hydrochloride is a potent, selective, and orally active inhibitor of PI3Kδ, with an IC50 of 1 nM at 1 mM ATP. It exhibits approximately 20000-fold selectivity over other PI3K class I isoforms and is used for the research of relapsed or refractory B-cell malignancies.

  • Potent, selective, and orally active inhibitor of PI3Kδ
  • High potency and selectivity for PI3Kδ
  • Used for research of relapsed or refractory B-cell malignancies
  • Inhibits proliferation of MCL and DLBCL cell lines
  • Inhibits tumor growth in BALB/c mice bearing A20 murine lymphoma cells
  • Potential therapeutic agent for B-cell malignancies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.